Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 17, 2021
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
Journal: The New England journal of medicine
Published: March 13, 2018
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.
Journal: Arthritis research & therapy
Published: November 14, 2017
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 01, 2017
Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials.
Journal: Journal of Crohn's & colitis
Published: June 27, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026